Astellas Pharma Inc
Clinical trials sponsored by Astellas Pharma Inc, explained in plain language.
-
New drug targets tough cancers with specific gene flaw
Disease control OngoingThis early-stage study tests a new drug called ASP4396 in adults with advanced solid tumors that have a specific KRAS G12D mutation. The drug is given by IV infusion, and the main goals are to check safety, find the right dose, and see how the body handles it. About 175 participa…
Phase: PHASE1 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New targeted therapy shows promise in Tough-to-Treat leukemia
Disease control OngoingThis study tested a new drug called ASP2215 against standard chemotherapy in 276 adults with a specific type of acute myeloid leukemia (FLT3-mutated) that had come back or not responded to initial treatment. The goal was to see if ASP2215 helped people live longer (overall surviv…
Phase: PHASE3 • Sponsor: Astellas Pharma Inc • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC